Combined Imaging Identified Higher Heart Risk

Patients with concordant heart scan results faced a higher risk of major adverse cardiac events at one year.

Updated on Sept. 28, 2026 in Heart Disease

Isometric editorial illustration of a stylized, geometric human heart model featuring layered segments, representing medical diagnostic imaging. — Researchers identified that dual heart imaging, combining late gadolinium enhancement and FDG uptake, better predicts heart-related complication risks in patients. AI Illustration. Upload story photo >

Live Poll

Do you trust advanced diagnostic imaging to improve the accuracy of your medical treatment?

Researchers have found that pairing two types of heart imaging can better predict the risk of major adverse cardiac events in individuals with suspected myocarditis. The study of 100 patients provides a new way to assess prognosis for those with inflammatory heart disease.

Why it matters

Accurate risk assessment remains challenging in cases of suspected inflammatory cardiomyopathy, and this multimodality approach helps clinicians better identify those who may face the most serious heart-related complications.

In a cohort study of 100 patients, those with concordant findings on both cardiac magnetic resonance and FDG PET/CT scans showed an adjusted hazard ratio of 3.61 for major adverse cardiac events at one year. These findings are preliminary as researchers plan to prospectively enroll larger, broader populations.

The players

American Society of Nuclear Cardiology

A professional organization dedicated to the study and advancement of non-invasive cardiac imaging techniques.

The details

The research defined concordant imaging as the presence of both focal late gadolinium enhancement and FDG uptake within at least one myocardial segment. This dual-imaging strategy allows clinicians to better pinpoint areas of active inflammation that correlate with a higher likelihood of heart failure, dangerous arrhythmias, or death. Following these imaging results, 31% of concordant patients received immunosuppressive therapy compared to 9% of those with discordant imaging.

September 2026: Research findings were reported at the American Society of Nuclear Cardiology meeting.

Health Landscape

This research marks a departure from reliance on single-modality imaging for myocarditis, reflecting a broader trend toward multimodality protocols to improve prognostic accuracy. It highlights the evolution of diagnostic cardiology as providers increasingly combine functional and structural data.

If you have been diagnosed with suspected myocarditis, ask your cardiologist if your imaging results suggest a high risk for complications like heart failure or arrhythmias. It is worth discussing with your doctor whether a multimodality approach is appropriate for your specific clinical history.

The takeaway

Combined heart imaging can provide important prognostic insights for patients dealing with inflammatory cardiomyopathy. If you have concerns about your cardiac risk, focus on tracking symptoms such as shortness of breath or irregular heartbeats and discuss these patterns with a heart specialist.